v3.26.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Cash Flows From Operating Activities    
Net loss $ (13,843) $ (2,488)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on issuance of common stock 2,703 0
Placement agent warrant offering expense 138 0
Gain on previously liquidated equity securities (94) 0
Gain on sale of asset 0 (10,000)
Interest accretion on escrow receivable (14) 0
Accretion on investments 0 (38)
Depreciation and amortization 215 266
Stock-based compensation 303 532
Non-cash lease expense 460 432
Inventory write-off 0 798
Increase (decrease) in cash resulting from changes in:    
Accounts receivable (2) 3
Inventory 0 (501)
Prepaid expenses and other assets 670 253
Accounts payable (623) 1,017
Accrued expenses (245) 717
Operating lease liability (495) (452)
Net cash used in operating activities (10,827) (9,461)
Cash Flows From Investing Activities    
Purchases of fixed assets 0 (13)
Proceeds from sale of asset 0 9,000
Purchases of investments 0 (2,962)
Maturities of investments 0 3,000
Proceeds from previously liquidated equity securities 94 0
Net cash provided by investing activities 94 9,025
Cash Flows From Financing Activities    
Proceeds from issuance of common stock, net 4,808 8,847
Repayment of insurance premium financing liability (363) 0
Net cash provided by financing activities 4,445 8,847
Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash (6,288) 8,411
Cash, cash equivalents, and restricted cash at beginning of period 11,455 3,044
Cash, cash equivalents, and restricted cash at end of period 5,167 11,455
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets    
Cash and cash equivalents 5,024 11,312
Restricted cash 143 143
Cash, cash equivalents, and restricted cash at end of period 5,167 11,455
Supplemental Disclosure of Cash Flow Information:    
Escrow receivable 0 1,000
Income taxes paid 2 2
Interest paid 12 10
Liability to be settled in equity 0 218
Financed insurance premium exchanged for prepaid insurance 353 128
Common stock warrant liabilities $ 5,700 $ 0